Clinical Trials Browser

Malignant Solid Tumour × Sunitinib × Other solid neoplasm × Clear all

NCT01286896 2025-07-10

Use of Individual Pharmacokinetically (PK)-Guided Sunitinib Dosing: A Feasibility Study in Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Malignant Solid Tumour